American firearms manufacturer Smith & Wesson (NASDAQ: SWBI) announced better-than-expected revenue in Q1 CY2026, with sales up 26.7% year on year to $178.4 million. Its non-GAAP profit of $0.36 per share was 56.5% above analysts’ consensus estimates.
Is now the time to buy Smith & Wesson? Find out by accessing our full research report, it’s free.
Smith & Wesson (SWBI) Q1 CY2026 Highlights:
- Revenue: $178.4 million vs analyst estimates of $155.3 million (26.7% year-on-year growth, 14.9% beat)
- Adjusted EPS: $0.36 vs analyst estimates of $0.23 (56.5% beat)
- Adjusted EBITDA: $30.94 million vs analyst estimates of $24.53 million (17.3% margin, 26.1% beat)
- Operating Margin: 12%, up from 10.6% in the same quarter last year
- Free Cash Flow Margin: 39.1%, up from 23.8% in the same quarter last year
- Market Capitalization: $651.8 million
Company Overview
With a history dating back to 1852, Smith & Wesson (NASDAQ: SWBI) is a firearms manufacturer known for its handguns and rifles.
Revenue Growth
Examining a company’s long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Smith & Wesson’s demand was weak over the last five years as its sales fell at a 13.1% annual rate. This wasn’t a great result and is a sign of poor business quality.
We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new product or trend. Smith & Wesson’s annualized revenue declines of 1.1% over the last two years suggest its demand continued shrinking. 
This quarter, Smith & Wesson reported robust year-on-year revenue growth of 26.7%, and its $178.4 million of revenue topped Wall Street estimates by 14.9%.
Looking ahead, sell-side analysts expect revenue to decline by 3.1% over the next 12 months, a slight deceleration versus the last two years. This projection is underwhelming and indicates its products and services will see some demand headwinds.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
Operating Margin
Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses — everything from the cost of goods sold to advertising and wages. It’s also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes.
Smith & Wesson’s operating margin has generally stayed the same over the last 12 months, and we generally like to see margin increases due to economies of scale and cost efficiency over time.
This quarter, Smith & Wesson generated an operating margin profit margin of 12%, up 1.3 percentage points year on year. This increase was a welcome development and shows it was more efficient.
Earnings Per Share
Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth — for example, a company could inflate its sales through excessive spending on advertising and promotions.
Sadly for Smith & Wesson, its EPS declined by 39% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.
In Q1, Smith & Wesson reported adjusted EPS of $0.36, up from $0.20 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Smith & Wesson’s full-year EPS to shrink by 17.5% from $0.40 to $0.33.
Key Takeaways from Smith & Wesson’s Q1 Results
It was good to see Smith & Wesson beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 13.7% to $15.63 immediately after reporting.
Smith & Wesson may have had a good quarter, but does that mean you should invest right now? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).
